UPLOAD Filing
Ernexa Therapeutics Inc.
Date: April 25, 2025 · CIK: 0000748592 · Accession: 0000000000-25-004418
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-286581
Letter
Re: Ernexa Therapeutics Inc. Registration Statement on Form S-3 Filed April 16, 2025 File No. 333-286581 Dear Sanjeev Luther:
April 25, 2025
Sanjeev Luther Chief Executive Officer Ernexa Therapeutics Inc. 1035 Cambridge Street, Suite 18A Cambridge, MA 02141
This is to advise you that we have not reviewed and will not review your registration statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Lauren Hamill at 303-844-1008 with any questions.
Sincerely,
Division of
Corporation Finance
Office of Life
Sciences
cc: Jeff Cahlon
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> April 25, 2025 Sanjeev Luther Chief Executive Officer Ernexa Therapeutics Inc. 1035 Cambridge Street, Suite 18A Cambridge, MA 02141 Re: Ernexa Therapeutics Inc. Registration Statement on Form S-3 Filed April 16, 2025 File No. 333-286581 Dear Sanjeev Luther: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Lauren Hamill at 303-844-1008 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Jeff Cahlon </TEXT> </DOCUMENT>